AU2001270934A1 - A method for correcting the immune system of live body - Google Patents

A method for correcting the immune system of live body

Info

Publication number
AU2001270934A1
AU2001270934A1 AU2001270934A AU7093401A AU2001270934A1 AU 2001270934 A1 AU2001270934 A1 AU 2001270934A1 AU 2001270934 A AU2001270934 A AU 2001270934A AU 7093401 A AU7093401 A AU 7093401A AU 2001270934 A1 AU2001270934 A1 AU 2001270934A1
Authority
AU
Australia
Prior art keywords
correcting
immune system
live body
live
immune
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001270934A
Inventor
Valerii Khazhmuratovich Zhilov
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MEDINKOR ZMM AG
Original Assignee
MEDINKOR ZMM AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MEDINKOR ZMM AG filed Critical MEDINKOR ZMM AG
Publication of AU2001270934A1 publication Critical patent/AU2001270934A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/502—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001270934A 2000-08-02 2001-07-20 A method for correcting the immune system of live body Abandoned AU2001270934A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
RU2000120330/14A RU2167659C1 (en) 2000-08-02 2000-08-02 Method of correction of immune system of living body
RU2000/120330 2000-08-02
PCT/IB2001/001293 WO2002009681A2 (en) 2000-08-02 2001-07-20 A method for correcting the immune system of live body

Publications (1)

Publication Number Publication Date
AU2001270934A1 true AU2001270934A1 (en) 2002-02-13

Family

ID=20238611

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001270934A Abandoned AU2001270934A1 (en) 2000-08-02 2001-07-20 A method for correcting the immune system of live body

Country Status (6)

Country Link
US (1) US20030195183A1 (en)
EP (1) EP1315497A2 (en)
AU (1) AU2001270934A1 (en)
RU (1) RU2167659C1 (en)
UA (1) UA81744C2 (en)
WO (1) WO2002009681A2 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1203587B1 (en) * 2000-03-28 2010-07-14 Abidov, Musea Tazhudinovich A medicament and method for the production thereof
AU2002220241A1 (en) * 2000-12-01 2002-06-11 Iconix Pharmaceuticals, Inc. Parb inhibitors
US7326690B2 (en) * 2002-10-30 2008-02-05 Bach Pharma, Inc. Modulation of cell fates and activities by phthalazinediones
US8592421B2 (en) 2003-08-04 2013-11-26 Valery Khazhmuratovich Zhilov Cyclic bioisosters of purine system derivatives and a pharmaceutical composition based thereon
US7732616B2 (en) * 2003-11-19 2010-06-08 Array Biopharma Inc. Dihydropyridine and dihydropyridazine derivatives as inhibitors of MEK and methods of use thereof
MXPA06005657A (en) * 2003-11-19 2006-08-23 Array Biopharma Inc Heterocyclic inhibitors of mek and methods of use thereof.
US7517994B2 (en) * 2003-11-19 2009-04-14 Array Biopharma Inc. Heterocyclic inhibitors of MEK and methods of use thereof
US7759337B2 (en) * 2005-03-03 2010-07-20 Amgen Inc. Phthalazine compounds and methods of use
CN101626767A (en) * 2005-05-18 2010-01-13 阵列生物制药公司 The heterocycle inhibitor of MEK and using method thereof
WO2008129029A1 (en) * 2007-04-23 2008-10-30 Novartis Ag Phthalazine and isoquinoline derivatives with slp receptor modulating activities
US8497269B2 (en) 2008-10-10 2013-07-30 Amgen Inc. Phthalazine compounds as p38 map kinase modulators and methods of use thereof
WO2010042646A1 (en) 2008-10-10 2010-04-15 Amgen Inc. Aza- and diaza-phthalazine compounds as p38 map kinase modulators and methods of use thereof
CA2791327C (en) 2010-03-01 2018-10-30 Metriopharm Ag Crystalline forms of 5-amino-2,3-dihydrophthalazine-1,4-dione sodium salt, pharmaceutical preparations containing the same, method for production of said forms and use of said forms for modulating the immune system
RU2550879C1 (en) * 2014-03-31 2015-05-20 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Ставропольский государственный аграрный университет" Method of staining blood smears for microscopic determination of structural organisation of cell phase activity
RU2635769C1 (en) * 2017-02-08 2017-11-15 Адмир Мусаевич Абидов Drug based on 5-amino-2,3-dihydrophthalazine-1,4-dione as quick-soluble film for transbuccal introduction
US20210379063A1 (en) * 2018-10-26 2021-12-09 Immunopharma Plus D.O.O. Oral aminodihydrophthalazinedione compositions and their use in the treatment of non-viral hepatitis

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2654689A (en) * 1950-10-28 1953-10-06 Ethyl Corp N, n'-phthalyl hydrazine fungicidal composition
JPS5334785A (en) * 1976-09-09 1978-03-31 Mitsubishi Chem Ind Ltd 1-substituted-4-halogeno-5, 6, 7, 8-tetrahydrophthalazines
GB2244704B (en) * 1990-05-04 1995-05-17 Consultants Suppliers Limited Substituted benzene compounds
JPH0736013B2 (en) * 1991-04-27 1995-04-19 一男 田畑 Reagent for occult blood detection
US5589483A (en) * 1994-12-21 1996-12-31 Geron Corporation Isoquinoline poly (ADP-ribose) polymerase inhibitors to treat skin diseases associated with cellular senescence
RU2113222C1 (en) * 1997-09-30 1998-06-20 Закрытое акционерное общество "Центр современной медицины "Медикор" Immunomodulating agent
EP1203587B1 (en) * 2000-03-28 2010-07-14 Abidov, Musea Tazhudinovich A medicament and method for the production thereof

Also Published As

Publication number Publication date
US20030195183A1 (en) 2003-10-16
WO2002009681A2 (en) 2002-02-07
WO2002009681A3 (en) 2002-05-16
EP1315497A2 (en) 2003-06-04
RU2167659C1 (en) 2001-05-27
UA81744C2 (en) 2008-02-11

Similar Documents

Publication Publication Date Title
AU2002218623A1 (en) Robot system
AU2002218627A1 (en) Robot system
AU6170900A (en) Publishing system for intranet
AU2001240115A1 (en) Method for the preparation of tetrahydrobenzothiepines
AU2001267188A1 (en) System and method for transferring funds
AU6607700A (en) Robotic system
AU2001255846A1 (en) Dental implant system
AU2001227600A1 (en) System and method for flexible software linking
GB2356995B (en) Autonomous off-board defensive aids system
AU2001270934A1 (en) A method for correcting the immune system of live body
AU2001239144A1 (en) Method for transferring intersystem connections
AU6697200A (en) Lyophilization method
AU2002222170A1 (en) Method and system for icosaborane implantation
HK1052702A1 (en) Method for the preparation of 5-carboxyphthalide.
AU2329300A (en) Dental implant system
AU2002214275A1 (en) Method for correcting sensor output
AU2825400A (en) Two-dimensional separating method
AU1730101A (en) Adaptive tolerance reference inspection system
AU2002218056A1 (en) Method for connecting metallic objects
AU2001240557A1 (en) Implant for cranioplastics
AU2001280674A1 (en) Mini-adenoviral vector system for vaccination
AU5003800A (en) Implant system
AU2001295658A1 (en) Method for 3d adaptation
AU1130901A (en) Method for the preparation of 5-carboxyphthalide
AU2001238996A1 (en) Method for individualising objects